Sandoz Group AG
SDZ
Rang in Aktien
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Aktienkurs
$96.18
Marktkapitalisierung
$41.62B
Veränderung (1 Tag)
0.99%
Veränderung (1 Jahr)
58.93%
Land
CH
Handel Sandoz Group AG (SDZ)
Kategorie
Healthcare
Dividendenrendite-Verlauf für Sandoz Group AG (SDZ)
Dividendenrendite (TTM) von Sandoz Group AG (Aktienkürzel: SDZ) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.44%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.44%
Dividendenrendite-Verlauf für Sandoz Group AG (SDZ) von 2020 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
| Jahr | Dividendenrendite | ändert |
|---|---|---|
| 2025 | 1.00% | -18.03% |
| 2024 | 1.22% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | Dividendenrendite | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 3.18% |
JP
|
|
| 0.19% |
CH
|
|
| 0.91% |
IN
|
